Positive EMA Decision for BioArctic's New Drug Candidate

Bioarctic's drug candidate for multiple system atrophy, exidavnemab, is recommended to be classified as an orphan drug, according to the European Medicines Agency (EMA).

A new life science cluster formed – “We are very strong in talent”

Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Ny motgång för Astra Zenecas ADC-kandidat

Astra Zenecas läkemedelskandidat Dato-DXd uppvisade ingen signifikant förbättring av överlevnaden hos bröstcancerpatienter jämfört med kemoterapi i en fas III-s...

Karriärcoachen om löner: ”Det finns inget rätt eller fel”

Vad är en rimlig lön för mitt jobb? Det är en fråga vi alla ställer oss. Men hur viktigt är det egentligen med högre lön? Det tycker karriärcoachen Tina Persson...

Cytel Sweden

Nytt ATMP-centrum invigt: “I framtiden ser vi cell- och genterapier på alla kliniker”

Idag invigdes Karolinska institutets och Karolinska universitetssjukhusets nya ATMP-centrum i Flemingsberg söder om Stockholm. ”ATMP-Centrum är inte bara en fys...

Medivir CEO on upcoming study: ”It's about working together with others”

Medivir is a small company with a big task: to take its drug candidate, via extensive clinical studies, all the way to a patient group that currently lacks appr...

AI automates testing of implant coatings

The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.

Explore 3D Testing of Deformation and Motions

Powerful measurement capabilities with the new ZEISS ARAMIS 1.

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

”The importance of stratification in a statistician’s August kitchen”

Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.

Kompauto Nordic AB

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on p...

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.

Medicon Village Science Park

RegSmart Life Science AB

ZEISS receives FDA clearance for INTRABEAM 700

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

TECHNIA AB